Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Targeting Angiogenesis, Inflammation and Oxidative Stress in Chronic Diseases presents recent advances in the vivid molecular pathways targeting angiogenesis, inflammation and oxidative stress that contribute very widely to the genesis of chronic diseases. The books will also highlight the drugs from natural and synthetic origin in the management/prevention/treatment of diseases along with the drug delivery approaches. The book's authors from various key institutions around the globe will deliver well-structured and well-designed chapters. The systematic presented information and knowledge…mehr
Targeting Angiogenesis, Inflammation and Oxidative Stress in Chronic Diseases presents recent advances in the vivid molecular pathways targeting angiogenesis, inflammation and oxidative stress that contribute very widely to the genesis of chronic diseases. The books will also highlight the drugs from natural and synthetic origin in the management/prevention/treatment of diseases along with the drug delivery approaches. The book's authors from various key institutions around the globe will deliver well-structured and well-designed chapters. The systematic presented information and knowledge will surely aid consistency and continuity. The multifaceted book is enriched with deep scientific contents. Each chapter will clearly define the facts, emerging role of molecular pathways and the targets and focus will be imparted on key challenges associated and the future directions that will provide torch bearer thing for the researchers to explore new targets in the domain.
Focuses on the pathogenesis of the disease, along with the molecular mechanism of action
Includes updates on strategic design/delivery of drugs targeting angiogenesis, inflammation, and oxidative stress
Provides recent advancements in the field of pathogenesis of chronic diseases
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Die Herstellerinformationen sind derzeit nicht verfügbar.
Inhaltsangabe
1. Understanding the role of angiogenesis, inflammation and oxidative stress in diabetes mellitus: insights into the past, present and future trends 2. Targeting angiogenesis, inflammation, and oxidative stress in obesity 3. Molecular role of angiogenesis, inflammation and oxidative stress in cancer 4. Rheumatoid arthritis: Its etiology, pathophysiology, and treatment 5. Inflammatory bowel diseases (IBDs) 6. Natural and synthetic agents targeting angiogenesis, oxidative stress, and inflammation in psoriasis 7. Unveiling the pharmacological and nanotechnological aspects for the management of hypertension: State-of-the-art and future perspectives 8. Decrypting the role of angiogenesis, inflammation and oxidative stress in pathogenesis of congestive heart failure: Nanotechnology as a boon for the management of congestive heart failure 9. Expatiating the role of angiogenesis, inflammation and oxidative stress in angina pectoris: A state-of-the-art on the drug delivery approaches 10. Targeting angiogenesis, inflammation, and oxidative stress in Alzheimer's siseases 11. Advancement in herbal drugs for the treatment of Parkinson's disease 12. Targeting angiogenesis, inflammation, and oxidative stress in depression 13. Role of inflammation, angiogenesis and oxidative stress in developing epilepsy 14. Diabetic retinopathy: Stressing the function of angiogenesis, inflammation and oxidative stress in the disease 15. Targeting the role of angiogenesis, inflammation and oxidative stress in pathogenesis of glaucoma: Strategic nanotechnology based drug delivery approaches 16. Age-associated macular degeneration: Epidemiologic features, complications, and potential therapeutic approaches 17. Intricate the potential role of nanotechnology as cutting-edge for management of hirsutism and gynecosmatia: A paradigm in therapeutics 18. Role of angiogenesis, inflammation and oxidative stress in polycystic ovary syndrome (PCOS): Current perspectives
1. Understanding the role of angiogenesis, inflammation and oxidative stress in diabetes mellitus: insights into the past, present and future trends 2. Targeting angiogenesis, inflammation, and oxidative stress in obesity 3. Molecular role of angiogenesis, inflammation and oxidative stress in cancer 4. Rheumatoid arthritis: Its etiology, pathophysiology, and treatment 5. Inflammatory bowel diseases (IBDs) 6. Natural and synthetic agents targeting angiogenesis, oxidative stress, and inflammation in psoriasis 7. Unveiling the pharmacological and nanotechnological aspects for the management of hypertension: State-of-the-art and future perspectives 8. Decrypting the role of angiogenesis, inflammation and oxidative stress in pathogenesis of congestive heart failure: Nanotechnology as a boon for the management of congestive heart failure 9. Expatiating the role of angiogenesis, inflammation and oxidative stress in angina pectoris: A state-of-the-art on the drug delivery approaches 10. Targeting angiogenesis, inflammation, and oxidative stress in Alzheimer's siseases 11. Advancement in herbal drugs for the treatment of Parkinson's disease 12. Targeting angiogenesis, inflammation, and oxidative stress in depression 13. Role of inflammation, angiogenesis and oxidative stress in developing epilepsy 14. Diabetic retinopathy: Stressing the function of angiogenesis, inflammation and oxidative stress in the disease 15. Targeting the role of angiogenesis, inflammation and oxidative stress in pathogenesis of glaucoma: Strategic nanotechnology based drug delivery approaches 16. Age-associated macular degeneration: Epidemiologic features, complications, and potential therapeutic approaches 17. Intricate the potential role of nanotechnology as cutting-edge for management of hirsutism and gynecosmatia: A paradigm in therapeutics 18. Role of angiogenesis, inflammation and oxidative stress in polycystic ovary syndrome (PCOS): Current perspectives
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826